| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,348.0840 | 1,348.0840 | 2,309.2180 | 2,489.9950 | 1,671.1170 |
| Cost of Revenue
|
-772.9760 | -772.9760 | -691.9840 | -547.6300 | -352.9620 |
|
Gross Profit
|
575.1080 | 575.1080 | 1,617.2340 | 1,942.3650 | 1,318.1550 |
| Selling, General and Administrative Expenses
|
-6,743.4500 | -6,743.4500 | -1,674.6830 | -711.5830 | -346.5340 |
| Depreciation, Amortization and Depletion
|
-29.0220 | -29.0220 | -28.9960 | -28.9000 | -27.6180 |
| Provision Expense/Write-Back
|
18.2020 | 18.2020 | -311.5390 | -13.8640 | 0 |
| Other Income/Expense, Operating
|
-144.8040 | -144.8040 | -41.5560 | -3.0480 | 8.7500 |
|
Operating Income/Expenses
|
-6,899.0740 | -6,899.0740 | -2,056.7740 | -757.3950 | -365.4020 |
|
Total Operating Profit/Loss
|
-6,323.9660 | -6,323.9660 | -439.5400 | 1,184.9700 | 952.7530 |
| Total Net Finance Income/Expense
|
-11.6450 | -11.6450 | -15.2850 | -16.6350 | -14.1170 |
| Net Investment Income
|
-11.8970 | -11.8970 | -30.2810 | 0.3370 | -0.6930 |
|
Other Income/Expense, Non-Operating
|
-9.4160 | -9.4160 | 0.3620 | -0.0330 | 0.0130 |
|
Non-Operating Income/Expenses, Total
|
-32.9580 | -32.9580 | -45.2040 | -16.3310 | -14.7970 |
|
Pretax Income
|
-6,356.9240 | -6,356.9240 | -484.7440 | 1,168.6390 | 937.9560 |
|
Provision for Income Tax
|
-965.8810 | -965.8810 | 53.2000 | -231.0300 | -157.3080 |
|
Net Income from Continuing Operations
|
-7,322.8050 | -7,322.8050 | -431.5440 | 937.6090 | 780.6480 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-7,322.8050 | -7,322.8050 | -431.5440 | 937.6090 | 780.6480 |
|
Net Income after Non-Controlling/Minority Interests
|
-7,322.8050 | -7,322.8050 | -431.5440 | 937.6090 | 780.6480 |
|
Net Income Available to Common Stockholders
|
-7,322.8050 | -7,322.8050 | -431.5440 | 937.6090 | 780.6480 |
|
Diluted Net Income Available to Common Stockholders
|
-7,322.8050 | -7,322.8050 | -431.5440 | 937.6090 | 780.6480 |
| Basic EPS
|
-236.70 | -236.70 | -53.15 | 111.09 | 92.49 |
| Diluted EPS
|
-236.70 | -236.70 | -53.15 | 111.09 | 92.49 |
|
Basic Weighted Average Shares Outstanding
|
30.9380 | 30.9380 | 8.1220 | 8.4400 | 8.4400 |
|
Diluted Weighted Average Shares Outstanding
|
30.9380 | 30.9380 | 8.4400 | 8.4400 | 8.4400 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-6,345.2790 | -6,345.2790 | -469.4590 | 1,185.2740 | 952.0730 |
|
EBITDA
|
-5,669.9270 | -5,669.9270 | -168.9020 | 1,372.0600 | 1,047.6060 |
|
Normalized EBITDA
|
-4,584.3650 | -4,584.3650 | -169.4340 | 1,371.7230 | 1,048.2990 |
|
Normalized Income
|
-6,237.2430 | -6,237.2430 | -432.0180 | 937.3387 | 781.2248 |
|
Total Unusual Items
|
1,085.5620 | 1,085.5620 | -0.5320 | -0.3370 | 0.6930 |
12/31/2022 - 10/2/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade